METiS Pharmaceuticals Technology has officially announced the completion of an Angel+ round and Pre-A round of financing of more than RMB100 million yuan. The Angel+ round was led by Sequoia Capital China Fund. Frees VC, Source Code Capital, Jingtai Technology, and Forcefield Venture also participated in the investment. The Pre-A round of financing was led […]

Sequoia Capital Leads Angel Round In AI Pharma Firm METiS comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.